Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK …
ASV Stuart, RH Shaw, X Liu, M Greenland, PK Aley… - The Lancet, 2022 - thelancet.com
Background Given the importance of flexible use of different COVID-19 vaccines within the
same schedule to facilitate rapid deployment, we studied mixed priming schedules …
same schedule to facilitate rapid deployment, we studied mixed priming schedules …
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a …
X Liu, RH Shaw, ASV Stuart, M Greenland, PK Aley… - The Lancet, 2021 - thelancet.com
Background Use of heterologous prime-boost COVID-19 vaccine schedules could facilitate
mass COVID-19 immunisation. However, we have previously reported that heterologous …
mass COVID-19 immunisation. However, we have previously reported that heterologous …
[HTML][HTML] Reduced neutralisation of SARS-CoV-2 omicron B. 1.1. 529 variant by post-immunisation serum
…, RH Shaw, P Supasa, C Liu, ASV Stuart… - Lancet (London …, 2022 - ncbi.nlm.nih.gov
According to WHO, SARS-CoV-2 is estimated to have caused 265 million infections and
more than 5 million deaths over the past 2 years. Current vaccines are based on the original …
more than 5 million deaths over the past 2 years. Current vaccines are based on the original …
Phase 1/2a safety and immunogenicity of an adenovirus 26 vector respiratory syncytial virus (RSV) vaccine encoding prefusion F in adults 18–50 years and RSV …
ASV Stuart, M Virta, K Williams, I Seppa… - The Journal of …, 2023 - academic.oup.com
Background Respiratory syncytial virus (RSV) remains a leading cause of pediatric morbidity,
with no approved vaccine. We assessed the safety and immunogenicity of the Ad26.RSV.…
with no approved vaccine. We assessed the safety and immunogenicity of the Ad26.RSV.…
[HTML][HTML] Safety and immunogenicity report from the com-COV study–a single-blind randomised non-inferiority trial comparing heterologous and homologous prime …
X Liu, RH Shaw, ASV Stuart, M Greenland, T Dinesh… - 2021 - papers.ssrn.com
Background: Use of heterologous prime-boost COVID-19 vaccine schedules could facilitate
mass COVID-19 immunisation, however we have previously reported that heterologous …
mass COVID-19 immunisation, however we have previously reported that heterologous …
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory …
RH Shaw, X Liu, ASV Stuart, M Greenland… - The Lancet …, 2022 - thelancet.com
Background Priming COVID-19 vaccine schedules have been deployed at variable intervals
globally, which might influence immune persistence and the relative importance of third-…
globally, which might influence immune persistence and the relative importance of third-…
[HTML][HTML] Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study–A single-blind, randomised trial incorporating mRNA …
RH Shaw, M Greenland, ASV Stuart, PK Aley… - Journal of Infection, 2023 - Elsevier
Background Heterologous COVID vaccine priming schedules are immunogenic and effective.
This report aims to understand the persistence of immune response to the viral vectored, …
This report aims to understand the persistence of immune response to the viral vectored, …
Gilbert Talbot, Seventh Earl of Shrewsbury: An Elizabethan Courtier and His Music
DC Price - Music & Letters, 1976 - JSTOR
… of Mary Stuart gave her to arrange a … Stuart claim to the English throne, Charles, Earl of
Lennox. Although he died within a year, the child of this unfortunate alliance, Lady Arabella Stuart…
Lennox. Although he died within a year, the child of this unfortunate alliance, Lady Arabella Stuart…
The collective voice of early phase COVID-19 vaccine trial participants: Insights for improving confidence in novel vaccines
…, R te Water Naude, ASV Stuart… - Human Vaccines & …, 2023 - Taylor & Francis
In early 2020, adult volunteers were invited to participate in a first-in-human trial of the
COVID-19 vaccine, ChAdOx1 nCoV-19, in the United Kingdom (UK) at the height of the global …
COVID-19 vaccine, ChAdOx1 nCoV-19, in the United Kingdom (UK) at the height of the global …
'The Duchess of Malfi'and Catherine of Valois
J Lares - Notes and Queries, 1993 - go.gale.com
… plight of Arabella Stuart may have been echoed in Webster's The Duchess of Malfi.(1) Arabella,
… Arabella was captured while she lingered in mid-channel to make sure of her husband's …
… Arabella was captured while she lingered in mid-channel to make sure of her husband's …
